Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
BON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D Platform
2025-09-02 20:30
SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift
2025-09-02 19:00
Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting
2025-09-02 18:00
Unlocking the Potential of Cyclic Peptide Therapeutics: Viva Biotech's Discovery Insights
2025-09-02 17:52
Akeso Announces Completion of Patient Enrollment in Phase III Clinical Trial for Ivonescimab as First-Line Treatment for Biliary Tract Cancer Compared to PD-L1 Therapy
2025-09-02 16:00
AMI Pharm's AYP-101 Shows Promise in Phase 2 Trial, Signaling a Breakthrough in Nonsurgical Fat Reduction
2025-09-01 21:00
Introducing FitTransformer: The World's First Modular Smart Gym That Transforms Your Home Workouts
2025-09-01 16:00
Jenscare, releases 2025H1 interim results
2025-09-01 13:00
Jacobio Pharma Announces 2025 Interim Results
2025-08-30 00:25
Lifezoom Updates: Refining Efficient Light Therapy Products Based on Customer Insights
2025-08-29 23:21
United Imaging Healthcare Reports 2025H1 Financial Results: Achieves Record Revenue in Overseas market
2025-08-29 20:00
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market
2025-08-29 19:30
Taiwan's Smart Healthcare Pavilion Presents Precision Oncology and Telemedicine Applications at Taiwan Expo USA 2025
2025-08-29 17:32
Celaid Therapeutics have executed a collaborative research agreement with AGC on Expansion and Functional Evaluation of iPSC-HSPCs
2025-08-28 22:00
D3 Bio, Inc. Announces FDA Breakthrough Therapy Designation and Orphan Drug Designation for D3S-001 for the Treatment of Patients with KRAS G12C-Mutated Cancers
2025-08-28 21:00
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee
2025-08-28 20:00
WuXi Biologics' Near-Term and Net-Zero Targets Approved by SBTi
2025-08-28 17:00
Top Thermal Camera Manufacturer Raytron Makes Breakthroughs in Scientific Research
2025-08-28 14:00
FIRST CLINICAL EVIDENCE PUBLISHED ON AROA's ENIVO™ SYSTEM FOR SURGICAL DEAD SPACE MANAGEMENT.
2025-08-28 12:29
Ascletis Announces Favorable and Differentiated Pharmacokinetic Profile of ASC30 Oral Once-Daily Tablet in Its U.S. Phase Ib Multiple Ascending Dose Study
2025-08-28 07:45